Povorcitinib beneficial for moderate-to-severe hidradenitis suppurativa

2 months ago 10
For patients with moderate-to-severe hidradenitis suppurativa (HS), povorcitinib (an oral Janus kinase 1 inhibitor) is beneficial, according to a survey published online July 23 successful Nature Medicine.
Read Entire Article